Literature DB >> 8867073

Epidemiology of multiple sclerosis in Arabs in Jordan: a comparative study between Jordanians and Palestinians.

A S Najim Al-Din1, A Kurdi, A Mubaidin, M El-Khateeb, R W Khalil, A L Wriekat.   

Abstract

In a 2-year hospital-based study in Jordan 131 Arab multiple sclerosis patients were identified including 84 Palestinians and 36 Jordanians. Based on MS/ALS case ratio, multiple sclerosis was found to be twice as common among Palestinians than Jordanians. Other than the less marked female preponderance among Jordanian patients, the disease had the same clinical and paraclinical characteristics in both groups. It was more likely for Palestinian and Jordanian patients to originate from the northern parts of their countries, to be Rh negative and to be HLA-DR2 positive than their controls. Palestinians (patients and controls) did not show significant differences from Jordanians (patients and controls) in relation to their eye color, ABO and Rh blood groups distribution nor the HLA-DR or HLA-DQ (apart from HLA-DQ3) epitopes frequency, thus not offering any significant difference in the genetic-racial markers studies to explain the difference in the observed disease susceptibility. Previous studies demonstrated that 2 racially different populations sharing the same environment can have different risk of developing multiple sclerosis, but this study has shown that this can also be true for 2 racially similar populations sharing the same environment.

Entities:  

Mesh:

Year:  1996        PMID: 8867073     DOI: 10.1016/0022-510x(95)00276-8

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  8 in total

1.  Multiple sclerosis in Jordan: A clinical and epidemiological study.

Authors:  Khalid El-Salem; Ehsan Al-Shimmery; Khalid Horany; Ali Al-Refai; Kefah Al-Hayk; Yousef Khader
Journal:  J Neurol       Date:  2006-04-28       Impact factor: 4.849

2.  HLA class II alleles in patients with multiple sclerosis in the Biscay province (Basque Country, Spain).

Authors:  Oscar Fernández; Alfredo R-Antigüedad; María Jesús Pinto-Medel; Mari Mar Mendibe; Nestor Acosta; Begoña Oliver; Miguel Guerrero; Marcos Papais-Alvarenga; Victoria Fernández-Sánchez; Laura Leyva
Journal:  J Neurol       Date:  2009-12       Impact factor: 4.849

3.  Are public hospitals reforming efficiently in West Bank?

Authors:  Wasim I M Sultan; José Crispim
Journal:  Confl Health       Date:  2018-11-05       Impact factor: 2.723

4.  Macular ganglion cell complex parameters by optical coherence tomography in cases of multiple sclerosis without optic neuritis compared to healthy eyes.

Authors:  Nancy M Lotfy; Tariq Alasbali; Rajiv Khandekar
Journal:  Indian J Ophthalmol       Date:  2019-05       Impact factor: 1.848

5.  Preliminary study related the incidence of methylprednisolone pulse therapy in patients visited multiple sclerosis clinic located at the isfahan kashani hospital.

Authors:  Zahra Tolou-Ghamari; Vahid Shaygannejad; Fereshteh Ashtari
Journal:  Int J Prev Med       Date:  2013-05

6.  What is the Real Fate of Vitamin D in Multiple Sclerosis?

Authors:  Vahid Shaygannejad; Zahra Tolou-Ghamari
Journal:  Int J Prev Med       Date:  2013-05

7.  Study of type a and B behavior patterns in patients with multiple sclerosis in an Iranian population.

Authors:  Vahid Shaygannejad; Sedigheh Rezaei Dehnavi; Fereshteh Ashtari; Somayeh Karimi; Leila Dehghani; Rokhsareh Meamar; Zahra Tolou-Ghamari
Journal:  Int J Prev Med       Date:  2013-05

8.  ABO blood group distributions in multiple sclerosis patients from Basque Country; O- as a protective factor.

Authors:  Itziar Lopetegi; Amaia Muñoz-Lopetegi; Maialen Arruti; Alvaro Prada; Sabin Urcelay; Javier Olascoaga; David Otaegui; Tamara Castillo-Triviño
Journal:  Mult Scler J Exp Transl Clin       Date:  2019-11-15
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.